Treatt Plc · LSE:TET
Treatt — Shareholder Meeting (2022)
9 slides from Treatt's shareholder meeting presentation, 2022
Slide 1: Annual General Meeting for the year ended 30 September 2021
ANNUAL GENERAL MEETING FOR THE YEAR ENDED 30 SEPTEMBER 2021 Daemmon Reeve — Chief Executive Officer
Slide 2: Track record of PBT growth - 2021: +41.3%
A TRACK RECORD OF PBT GROWTH - 2021: +41.3% Uy TREATT PROFIT BEFORE TAX!2 £20.9m 50% £14.8m £12.7m £13.3m £11.7m 50% 46% AT 41% 32% 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Traded Evolution from Traded to Added-Value » Added-Value /
Slide 3: Dividend per share - 2021: +25.0%
DIVIDEND PER SHARE - 2021: +25.0% A ep TREATT 7.50p 6.00p 5.50p 4.16 5.10p 4.80p 3.80p 4.35 3.50p 4.04p , 3.35p 3.70p 3.84p 3.00p 2.76p 3.10p 2.60p Abs 2.08p 2.00p iS 1.60p 1.70p 1.84p 1.28 1.35p ° a 1410p 1.24p P 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Slide 4: Benefitting from consumer trends
BENEFITTING FROM CONSUMER TRENDS (TREAT
Slide 5: Benefits of the new UK site
BENEFITS OF THE NEW UK SITE CAPACITY, EFFICIENCY, INNOVATION AND COLLABORATION Transfer complete by mid-2023 Capacity — materially higher volumes possible Productivity - significant technological advances Innovation — significantly expanded R&D labs Client collaboration - customer co-creation within
Slide 6: UK site recap of progress
UK SITE RECAP OF PROGRESS A op TREATT What we have done Office Fitout Laboratory Fitout (started) Applications Staff movement What's going on now Commissioning of production equipment Commissioning of Warehouse Management System What is left to do Transition of the manufacturing operation
Slide 7: Production
Production
Slide 8: Outlook
OUTLOOK * Continued growth expected ¢ Category opportunities including coffee ¢ Geographical opportunities building in China ¢ Strengthening executive team to support growth: * Chief People Officer - Jonathan Whitworth * Chief Innovation Officer - Wolfgang Tosch * Reversion to historic H1/H2 split *
Slide 9: Thank you, any questions?
A op TREATT THANK YOU Any QUESTIONS? A u TREATT